Anna Dysko

Associate Director Business Development @Oxford Nanopore Technologies

Oxford, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2024 — Present

Associate Director Business Development @Oxford Nanopore Technologies

View department →

Oxford, GB

Building new oncology portfolio of partnerships with biopharma and biotech businesses, including large corporations and start ups. Leading the entire process from prospecting, deal scoping and various types of contract negotiation (e.g. bespoke complex commercial, development, research and license agreements) while working collaboratively with internal stakeholders including Legal, Finance, Sales, Marketing, Product Management, Quality and RND and presenting business cases to the C-suite of the companyManaging existing portfolio of partners - maintaining trusted relationship, ensuring smooth progress and milestones completion of committed programmes

EDUCATION

2007 — 2010

University of Warsaw

Bachelor's degree, Life Science and Environmental Protection

2012 — 2016

University of Oxford

Doctor of Philosophy (PhD), Chemical Biology

2020 — 2020

CIM | The Chartered Institute of Marketing

Cert, Strategic Marketing and Digital Marketing

2010 — 2012

University of East Anglia

Master of Science (MSc), Chemical Biology

N/A

Harvard Medical School

Cancer genomics and precision oncology

2021 — 2021

The London School of Economics and Political Science (LSE)

Master of Business Administration - MBA, Business Administration and Management, General

ABOUT ANNA DYSKO

I am dedicated, creative and focused professional with experience in commercialisation, global strategic marketing and product development from major global life science companies. I am passionate about scientific innovation and precision medicine.Scientifically, I am an expert in gene therapy, antibodies science, NGS and genomics with 8 years’ experience in both top academic institutes and world-leading industry. I completed my PhD from University of Oxford developing gene therapies, then spent 3 years at Illumina working with Next Generation Sequencing. In my next role at the top antibody company abcam I was responsible for global marketing strategy for the Epigenetics and cancer research area. Currently I\'m working at Oxford Nanopore Technology developing global market growth strategies for cancer research. I have drive for learning, sharing and contributing into great initiatives that will contribute to society and improve human life.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Anna Dysko — Associate Director Business Development at Oxford Nanopore Technologies in Oxford, GB | Unifers